Skip to content

Nasdaq · CIK 0000009326

BCPC BALCHEM CORP

Insider trading from SEC Form 4. Last filing Feb 14, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company

Signals

Open-market buys and sells at BALCHEM CORP, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Congressional trades

2 trades in BCPC disclosed by members of Congress under the STOCK Act. All congressional trades.

MemberTypeAssetAmountTradedFiled
Gilbert Ray Cisneros, Jr.
House · D-CA
PurchaseBCPC
Balchem Corporation - Common Stock
$1,001 to $15kJul 10, 2026
56 days after the trade
Josh Gottheimer
House · D-NJ
Partial saleBCPC
Balchem Corporation - Common Stock
$1,001 to $15kApr 9, 2025
35 days after the trade

Transactions

The last 43 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Feb 12, 2025Fish Kathleen B
director
AGrant or award
Common Stock
+980$0.00$02,559Feb 14, 2025
Feb 12, 2025Reid Martin Luther
SVP Chief Supply Chain Officer
AGrant or award
Common Stock
+1,000$0.00$06,761Feb 14, 2025
Feb 12, 2025Tignor Michael Brent
SVP & Chief HR Officer
AGrant or award
Common Stock
+1,290$0.00$08,072Feb 14, 2025
Feb 12, 2025van Gunsteren Job Leonard
SVP and GM, Specialty Products
AGrant or award
Common Stock
+410$0.00$08,692Feb 14, 2025
Feb 12, 2025Harris Theodore L
Chairman, President & CEO
AGrant or award
Common Stock
+6,600$0.00$068,237Feb 14, 2025
Feb 12, 2025Miyata Hatsuki
EVP, Gen. Counsel & Secretary
AGrant or award
Common Stock
+1,840$0.00$06,672Feb 14, 2025
Feb 12, 2025Bengtsson Carl Martin
EVP & Chief Financial Officer
AGrant or award
Common Stock
+2,360$0.00$020,528Feb 14, 2025
Feb 12, 2025Boned Frederic
SVP/GM, Human Nutri. & Health
AGrant or award
Common Stock
+1,580$0.00$06,730Feb 14, 2025
Feb 12, 2025Backus William A.
VP & Chief Accounting Officer
AGrant or award
Common Stock
+550$0.00$05,228Feb 14, 2025
Feb 12, 2025VICENTE MONICA
director
AGrant or award
Common Stock
+980$0.00$01,520Feb 14, 2025
Feb 12, 2025Wineinger Matthew David
director
AGrant or award
Common Stock
+980$0.00$07,142Feb 14, 2025
Feb 12, 2025Fischer David B
director
AGrant or award
Common Stock
+980$0.00$09,989Feb 14, 2025
Feb 12, 2025Knutson Daniel E
director
AGrant or award
Common Stock
+980$0.00$06,029Feb 14, 2025
Feb 12, 2025Rigaud Olivier
director
AGrant or award
Common Stock
+980$0.00$01,520Feb 14, 2025
Feb 13, 2025Sestrick Michael Robert
SVP & Chief Technology Officer
AGrant or award
Common Stock
+2,016$0.00$05,807Feb 14, 2025
Feb 13, 2025van Gunsteren Job Leonard
SVP and GM, Specialty Products
AGrant or award
Common Stock
+1,718$0.00$010,410Feb 14, 2025
Feb 13, 2025Bengtsson Carl Martin
EVP & Chief Financial Officer
AGrant or award
Common Stock
+5,432$0.00$025,960Feb 14, 2025
Feb 13, 2025Reid Martin Luther
SVP Chief Supply Chain Officer
AGrant or award
Common Stock
+2,889$0.00$09,650Feb 14, 2025
Feb 13, 2025Tignor Michael Brent
SVP & Chief HR Officer
AGrant or award
Common Stock
+2,207$0.00$010,279Feb 14, 2025
Feb 13, 2025Backus William A.
VP & Chief Accounting Officer
AGrant or award
Common Stock
+2,067$0.00$07,295Feb 14, 2025
Feb 13, 2025Harris Theodore L
Chairman, President & CEO
AGrant or award
Common Stock
+22,364$0.00$090,601Feb 14, 2025
Feb 13, 2025Sestrick Michael Robert
SVP & Chief Technology Officer
FTax withholding
Common Stock
-1,045$163.14$170k4,762Feb 14, 2025
Feb 13, 2025Backus William A.
VP & Chief Accounting Officer
FTax withholding
Common Stock
-1,073$163.14$175k6,222Feb 14, 2025
Feb 13, 2025van Gunsteren Job Leonard
SVP and GM, Specialty Products
FTax withholding
Common Stock
-964$163.14$157k9,446Feb 14, 2025
Feb 13, 2025Bengtsson Carl Martin
EVP & Chief Financial Officer
FTax withholding
Common Stock
-2,781$163.14$454k23,179Feb 14, 2025
Feb 12, 2025Miyata Hatsuki
EVP, Gen. Counsel & Secretary
AGrant or award
Stock Optionderivative
+6,000$0.00$06,000Feb 14, 2025
Feb 12, 2025Boned Frederic
SVP/GM, Human Nutri. & Health
AGrant or award
Stock Optionderivative
+5,200$0.00$05,200Feb 14, 2025
Feb 13, 2025Harris Theodore L
Chairman, President & CEO
FTax withholding
Common Stock
-11,442$163.14$1.9M79,159Feb 14, 2025
Feb 13, 2025Tignor Michael Brent
SVP & Chief HR Officer
FTax withholding
Common Stock
-1,156$163.14$189k9,123Feb 14, 2025
Feb 13, 2025Reid Martin Luther
SVP Chief Supply Chain Officer
FTax withholding
Common Stock
-1,059$163.14$173k8,591Feb 14, 2025
Feb 12, 2025van Gunsteren Job Leonard
SVP and GM, Specialty Products
AGrant or award
Stock Optionderivative
+1,400$0.00$01,400Feb 14, 2025
Feb 12, 2025Reid Martin Luther
SVP Chief Supply Chain Officer
AGrant or award
Stock Optionderivative
+3,300$0.00$03,300Feb 14, 2025
Feb 12, 2025Backus William A.
VP & Chief Accounting Officer
AGrant or award
Stock Optionderivative
+1,800$0.00$01,800Feb 14, 2025
Feb 12, 2025Tignor Michael Brent
SVP & Chief HR Officer
AGrant or award
Stock Optionderivative
+4,200$0.00$04,200Feb 14, 2025
Feb 12, 2025Harris Theodore L
Chairman, President & CEO
AGrant or award
Stock Optionderivative
+21,500$0.00$021,500Feb 14, 2025
Feb 12, 2025Bengtsson Carl Martin
EVP & Chief Financial Officer
AGrant or award
Stock Optionderivative
+7,700$0.00$07,700Feb 14, 2025
Feb 10, 2025van Gunsteren Job Leonard
SVP and GM, Specialty Products
FTax withholding
Common Stock
-258$159.39$41k8,282Feb 12, 2025
Feb 10, 2025Tignor Michael Brent
SVP & Chief HR Officer
FTax withholding
Common Stock
-334$159.39$53k6,782Feb 12, 2025
Feb 10, 2025Sestrick Michael Robert
SVP & Chief Technology Officer
FTax withholding
Common Stock
-305$159.39$49k3,791Feb 12, 2025
Feb 10, 2025Reid Martin Luther
SVP Chief Supply Chain Officer
FTax withholding
Common Stock
-319$159.39$51k5,761Feb 12, 2025
Feb 10, 2025Harris Theodore L
Chairman, President & CEO
FTax withholding
Common Stock
-3,071$159.39$489k61,637Feb 12, 2025
Feb 10, 2025Bengtsson Carl Martin
EVP & Chief Financial Officer
FTax withholding
Common Stock
-777$159.39$124k18,168Feb 12, 2025
Feb 10, 2025Backus William A.
VP & Chief Accounting Officer
FTax withholding
Common Stock
-310$159.39$49k4,678Feb 12, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BCPC insider trading: BALCHEM CORP | InsiderTell